At Dana-Farber Brigham Cancer Center, your health and safety, along with the health and safety of our staff, are our top priorities. As our cancer specialists continue to learn more about the rapidly evolving COVID-19 (2019 Novel Coronavirus) pandemic, we want to keep our new and existing cancer patients informed. Visit our COVID-19 FAQs: For Cancer Patients for answers to some of the common questions cancer patients and caregivers are asking about COVID-19.
Our surgeons are also active physician researchers; Dr. Bertagnolli serves as Group Chair for The Alliance for Clinical Trials in Oncology. The Alliance is an NCI-funded cancer cooperative group formed in 2011 by the merger of the American College of Surgeons Oncology Group, the Cancer and Leukemia Group B, and the North Central Cancer Treatment Group.
Back Row Left to Right: Dr. Matthew Nehs, Dr. Monica Bertagnolli, Dr. Thomas Clancy, Dr. Mark Fairweather, Dr. Jason Liu Front Row Left to Right: Dr. Jiping Wang, Dr. Nancy Cho, Dr. Gerard Doherty, Dr. Chandrajit Raut, Dr. Charles Yoon, Dr. George Molina